Hidden Cove Wealth Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$654K Buy
2,600
+369
+17% +$79.4K 0.36% 52
2026
Q1
$485K Buy
2,231
+200
+10% +$44.4K 0.31% 52
2025
Q4
$464K Buy
2,031
+125
+7% +$28.5K 0.3% 48
2025
Q3
$441K Buy
1,906
+528
+38% +$108K 0.29% 46
2025
Q2
$256K Buy
1,378
+35
+3% +$6.5K 0.19% 63
2025
Q1
$281K Buy
+1,343
New +$261K 0.22% 51

Other funds holding ABBV

Hidden Cove Wealth Management's ABBV Position: Q2 2026 in Review

Hidden Cove Wealth Management increased its AbbVie (ABBV) stake by 17% in Q2 2026, buying an estimated $79.4K and bringing the position to 2,600 shares worth $654K. The position accounts for 0.36% of the portfolio, ranked #52.

Hidden Cove Wealth Management first reported a position in ABBV in Q1 2025 and has held it in 6 quarters since. 1,174 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Hidden Cove Wealth Management held 2,600 shares of AbbVie worth $654K as of Q2 2026.
  • Hidden Cove Wealth Management bought 369 AbbVie shares in Q2 2026, an estimated $79.4K.
  • AbbVie made up 0.36% of Hidden Cove Wealth Management's portfolio in Q2 2026, its #52 holding.
  • Hidden Cove Wealth Management first reported a position in AbbVie in Q1 2025 and has held it in 6 quarters since.
  • 1,174 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Hidden Cove Wealth Management's 13F filing for Q2 2026, filed 22 Jul 2026.